<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2418">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03875326</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00146180</org_study_id>
    <secondary_id>1R01AG058724</secondary_id>
    <nct_id>NCT03875326</nct_id>
  </id_info>
  <brief_title>Stimulation to Improve Memory</brief_title>
  <acronym>STIM</acronym>
  <official_title>Testing High Definition Transcranial Direct Current Stimulation (HD-tDCS) as Treatment of Mild Cognitive Impairment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the effects of different doses of a form of non-invasive brain&#xD;
      stimulation for the treatment of individuals with mild cognitive impairment (MCI) and&#xD;
      dementia of the Alzheimer's Type (DAT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research study is being done to learn important information about the effects of weak&#xD;
      electrical stimulation on brain functioning in those with mild cognitive impairment (MCI) and&#xD;
      dementia of the Alzheimer's type (DAT). The findings will help determine &quot;how much&quot;&#xD;
      stimulation is needed to enhance memory and thinking abilities, how it affects brain&#xD;
      functioning, and who is most likely to benefit. Ultimately, this information may guide&#xD;
      treatment efforts for those at various stages of Alzheimer's disease. The study will use&#xD;
      brain imaging to see whether these treatments change how participants learn and remember&#xD;
      information. Functional magnetic resonance imaging (fMRI) and positron emission tomography&#xD;
      (PET) scans will be used. The study will also use cognitive tests and questionnaires to&#xD;
      examine whether participants' memory (and related abilities) change because of treatment. The&#xD;
      study will enroll participants with a diagnosis of MCI or DAT. It is expected but not&#xD;
      required that participants will be co-enrolled in the University of Michigan Memory and Aging&#xD;
      Project (UM-MAP; HUM00000382).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Eligible participants will be randomized 1:1:1:1 to receive either sham, 1mA, 2mA, or 3mA HD-tDCS for at least 5 sessions and up to 30 sessions using a blocked randomization design.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Lateral Temporal Cortex Connectivity</measure>
    <time_frame>Baseline fMRI and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Graph Theory Analysis via fMRI using arbitrary units of connectivity strength</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-Report of Contentment with Memory</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Multifactorial Memory Questionnaire (MMQ) Contentment Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report of Memory Mistakes</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Multifactorial Memory Questionnaire (MMQ) Ability Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report of Memory Strategies Used</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Multifactorial Memory Questionnaire (MMQ) Strategies Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Memory Functioning</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the RBANS Delayed Memory Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Overall Fluid Cognitive Abilities</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the NIH Toolbox Cognition Fluid Composite Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Working Memory Effects of HD-tDCS across daily sessions</measure>
    <time_frame>Baseline Session through Session 6 then weekly up to final session</time_frame>
    <description>Working memory accuracy measured by a discriminability ratio (2-back d' minus 0-back d') on a validated computerized N-Back task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Memory Accuracy Effects of HD-tDCS across daily sessions</measure>
    <time_frame>Baseline Session through Session 6 then weekly up to final session</time_frame>
    <description>Verbal memory accuracy measured by an accuracy score (percent correct) on a computerized Paired Associates task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Memory Reaction Time Effects of HD-tDCS across daily sessions</measure>
    <time_frame>Baseline Session through Session 6 then weekly up to final session</time_frame>
    <description>Verbal memory reaction time measured by a drift rate score (V; measured by the mean rate at which information is accumulated towards a boundary [correct or error response]) on a computerized Paired Associates task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability of HD-tDCS</measure>
    <time_frame>Prior to and immediately following each HD-tDCS session (&lt;60 Minutes)</time_frame>
    <description>Evaluated using standard questionnaires that arose from comprehensive reviews of the tDCS literature, this questionnaire was recently refined to include pre- and post-HD-tDCS symptom assessment. This will be administered prior to and immediately after every brain stimulation session (including sham).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of Blinding of HD-tDCS</measure>
    <time_frame>Immediately following HD-tDCS sessions 5 and final session (&lt;60 Minutes)</time_frame>
    <description>Evaluated using a standard single question administered after every brain stimulation session (including sham).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Default Mode Network Connectivity</measure>
    <time_frame>Baseline fMRI and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Graph Theory Analysis via fMRI using arbitrary units of connectivity strength to measure changes in the Default Mode Network, along with strength in and between other networks</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Inhibition Ability</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>A priori intent to measure through change in the NIH Toolbox Flanker Inhibitory Control and Attention Test Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Conceptualization Ability</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>A priori intent to measure through change in the NIH Toolbox Dimensional Change Card Sort Test Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Picture Sequence Memory</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>A priori intent to measure through change in the NIH Toolbox Picture Sequence Memory Test Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Working Memory Ability</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>A priori intent to measure through change in the NIH Toolbox List Sorting Working Memory Test Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Processing Speed</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>A priori intent to measure through change in the NIH Toolbox Pattern Comparison Processing Speed Test Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Cumulative Working Memory Performance Effects of HD-tDCS across daily sessions</measure>
    <time_frame>Baseline Session through Session 6 then weekly up to final session</time_frame>
    <description>A priori intent to explore d' change for each N-Back task condition (2-back, 0-back) in order to understand the overall effect of the HD-tDCS on task performance.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Global Cognition</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the Total RBANS Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Visuospatial Functioning</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the RBANS Visuospatial Index score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Language Functioning</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the RBANS Language Index score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Attention</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the RBANS Attention Index score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Memory Functioning</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>Measured through change in the RBANS Immediate Memory Index score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Cognitive Functioning</measure>
    <time_frame>Baseline and post-intervention (after tDCS sessions 5 &amp; 30)</time_frame>
    <description>A priori intent to measure through changes in RBANS subtest scores</description>
  </other_outcome>
  <other_outcome>
    <measure>Cumulative Cognitive Change across Daily Consecutive Sessions</measure>
    <time_frame>After each HD-tDCS Session, daily</time_frame>
    <description>Measured through change in Cogstate or other comparable computerized cognitive testing scores across consecutive daily sessions</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Dementia of Alzheimer Type</condition>
  <arm_group>
    <arm_group_label>Sham Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham (placebo) dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 mA Dosage Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 mA Dosage Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 mA Dosage Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1 mA HD-tDCS</intervention_name>
    <description>Participants will receive HD-tDCS at 1 mA for 30 minutes, for between 5-30 sessions.</description>
    <arm_group_label>1 mA Dosage Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2 mA HD-tDCS</intervention_name>
    <description>Participants will receive HD-tDCS at 2 mA for 30 minutes, for between 5-30 sessions.</description>
    <arm_group_label>2 mA Dosage Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3 mA HD-tDCS</intervention_name>
    <description>Participants will receive HD-tDCS at 3 mA for 30 minutes, for between 5-30 sessions.</description>
    <arm_group_label>3 mA Dosage Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Participants will receive sham (placebo) HD-tDCS for 30 minutes, for between 5-30 sessions.</description>
    <arm_group_label>Sham Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of Mild Cognitive Impairment (MCI) or dementia of the Alzheimer's type (DAT)&#xD;
&#xD;
          2. Must be MRI compatible, criteria that also apply for High Definition transcranial&#xD;
             direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants&#xD;
             in the upper body or head)&#xD;
&#xD;
          3. Stable on relevant medications for at least 4 weeks prior to study enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Certain neurological diseases&#xD;
&#xD;
          2. Certain psychiatric conditions&#xD;
&#xD;
          3. Severe sensory impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Hampstead, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen M Schlaefflin, BS</last_name>
    <phone>734-936-7360</phone>
    <email>schlst@med.umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eileen A Robinson, RN-BC</last_name>
    <phone>734-763-1356</phone>
    <email>robinsoe@med.umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen M Schlaefflin, BS</last_name>
      <phone>734-936-7360</phone>
      <email>schlst@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Eileen Robinson, RN-BC, MPH, CCRC</last_name>
      <phone>734-763-1356</phone>
      <email>robinsoe@med.umich.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Benjamin Hampstead, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annalise Rahman-Filipiak, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2022</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2019</study_first_posted>
  <last_update_submitted>March 2, 2022</last_update_submitted>
  <last_update_submitted_qc>March 2, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Benjamin Hampstead, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Dementia</keyword>
  <keyword>Memory</keyword>
  <keyword>Cognitive Rehabilitation</keyword>
  <keyword>PET scan</keyword>
  <keyword>fMRI</keyword>
  <keyword>Brain Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

